Fatal Pulmonary Hypertension Associated with Short-Term Use of Fenfluramine and Phentermine
- 28 August 1997
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (9) , 602-606
- https://doi.org/10.1056/nejm199708283370904
Abstract
The dangers inherent in marked obesity have prompted physicians to advocate more aggressive strategies for weight reduction. One current strategy is the prescription of fenfluramine,1,2 either alone or in combination with phentermine, with the knowledge that the risks of the drugs must be balanced against the risks of continued obesity.Keywords
This publication has 19 references indexed in Scilit:
- Primary Pulmonary HypertensionChest, 1993
- Case 25-1992New England Journal of Medicine, 1992
- IntroductionClinical Pharmacology & Therapeutics, 1992
- Primary Pulmonary Hypertension in Association with Human Immunodeficiency Virus Infection: A Possible Viral Etiology for Some Forms of Hypertensive Pulmonary ArteriopathyAmerican Review of Respiratory Disease, 1992
- Primary pulmonary hypertension and human immunodeficiency virus infection in a non-hemophiliac manHuman Pathology, 1992
- Irreversible pulmonary hypertension after treatment with fenfluramine.BMJ, 1986
- Plexogenic pulmonary arteriopathy and liver cirrhosis.Thorax, 1980
- Case 8-1976New England Journal of Medicine, 1976
- FenfluramineDrugs, 1975
- Drug-induced Pulmonary Hypertension?BMJ, 1971